These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30446928)

  • 1. High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.
    Chao CY; Al Khoury A; Aruljothy A; Restellini S; Wyse J; Afif W; Bitton A; Lakatos PL; Bessissow T
    Dig Dis Sci; 2019 Feb; 64(2):518-523. PubMed ID: 30446928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Syal G; Robbins L; Kashani A; Bonthala N; Feldman E; Fleshner P; Vasiliauskas E; McGovern D; Ha C; Targan S; Melmed GY
    Dig Dis Sci; 2021 Jan; 66(1):199-205. PubMed ID: 32170473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.
    Nalagatla N; Falloon K; Tran G; Borren NZ; Avalos D; Luther J; Colizzo F; Garber J; Khalili H; Melia J; Bohm M; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):502-509.e1. PubMed ID: 29944926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.
    Choy MC; Li Wai Suen CFD; Con D; Boyd K; Pena R; Burrell K; Rosella O; Proud D; Brouwer R; Gorelik A; Liew D; Connell WR; Wright EK; Taylor KM; Pudipeddi A; Sawers M; Christensen B; Ng W; Begun J; Radford-Smith G; Garg M; Martin N; van Langenberg DR; Ding NS; Beswick L; Leong RW; Sparrow MP; De Cruz P
    Lancet Gastroenterol Hepatol; 2024 Nov; 9(11):981-996. PubMed ID: 39236736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting response after infliximab salvage in acute severe ulcerative colitis.
    Choy MC; Seah D; Gorelik A; An YK; Chen CY; Macrae FA; Sparrow MP; Connell WR; Moore GT; Radford-Smith G; Van Langenberg DR; De Cruz P
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1347-1352. PubMed ID: 29266456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Ordás I; Domènech E; Mañosa M; García-Sánchez V; Iglesias-Flores E; Peñalva M; Cañas-Ventura A; Merino O; Fernández-Bañares F; Gomollón F; Vera M; Gutiérrez A; Garcia-Planella E; Chaparro M; Aguas M; Gento E; Muñoz F; Aguirresarobe M; Muñoz C; Fernández L; Calvet X; Jiménez CE; Montoro MA; Mir A; De Castro ML; García-Sepulcre MF; Bermejo F; Panés J; Esteve M
    Am J Gastroenterol; 2017 Nov; 112(11):1709-1718. PubMed ID: 28675163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Govani SM; Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Hardiman KM
    Dig Dis Sci; 2020 Jun; 65(6):1800-1805. PubMed ID: 31748921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.
    Seah D; Choy MC; Gorelik A; Connell WR; Sparrow MP; Van Langenberg D; Hebbard G; Moore G; De Cruz P
    J Gastroenterol Hepatol; 2018 Jan; 33(1):226-231. PubMed ID: 28618062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.
    Beswick L; Rosella O; Rosella G; Headon B; Sparrow MP; Gibson PR; van Langenberg DR
    J Crohns Colitis; 2018 Feb; 12(3):289-297. PubMed ID: 29121178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis.
    Gibson DJ; Hartery K; Doherty J; Nolan J; Keegan D; Byrne K; Martin ST; Buckley M; Sheridan J; Horgan G; Mulcahy HE; Cullen G; Doherty GA
    J Clin Gastroenterol; 2018 Jul; 52(6):e48-e52. PubMed ID: 28737646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis.
    Gibson DJ; Heetun ZS; Redmond CE; Nanda KS; Keegan D; Byrne K; Mulcahy HE; Cullen G; Doherty GA
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):330-335.e1. PubMed ID: 25086187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
    Sjöberg M; Walch A; Meshkat M; Gustavsson A; Järnerot G; Vogelsang H; Hertervig E; Novacek G; Friis-Liby I; Blomquist L; Angelberger S; Karlen P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Dejaco C; Magnuson A; Halfvarson J; Reinisch W; Tysk C
    Inflamm Bowel Dis; 2012 Feb; 18(2):212-8. PubMed ID: 21438096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
    Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
    Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
    Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
    Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
    J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.
    Shah SC; Naymagon S; Panchal HJ; Sands BE; Cohen BL; Dubinsky MC
    Inflamm Bowel Dis; 2018 Feb; 24(3):651-659. PubMed ID: 29462380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis.
    Moore H; Dolce P; Devas N; Baldassano R; Martinelli M
    United European Gastroenterol J; 2020 May; 8(4):425-435. PubMed ID: 32213038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective validation of AIIMS index as a predictor of steroid failure in patients with acute severe ulcerative colitis.
    Sahu P; Jain S; Kedia S; Vuyyuru SK; Sahni P; Sharma R; Panwar R; Das P; Gupta V; Makharia G; Travis S; Ahuja V
    Indian J Gastroenterol; 2022 Jun; 41(3):273-283. PubMed ID: 35474175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.